Pasar al contenido principal

DESCIFRANDO LAS CONSECUENCIAS DE LOS DIFERENTES TIPOS DE VARIACIONES GENETICAS EN LAS SECUENCIAS FORMADORAS DE AMILOIDES MEDIANTE MUTAGENESIS PROFUNDA

PID2021-127761OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation

  • Seuma, Mireia
  • Lehner, Ben, 1978-
  • Bolognesi, Benedetta
Multiplexed assays of variant effects (MAVEs) guide clinical variant interpretation and reveal disease mechanisms. To date, MAVEs have focussed on a single mutation type-amino acid (AA) substitutions-despite the diversity of coding variants that cause disease. Here we use Deep Indel Mutagenesis (DIM) to generate a comprehensive atlas of diverse variant effects for a disease protein, the amyloid beta (Aβ) peptide that aggregates in Alzheimer's disease (AD) and is mutated in familial AD (fAD). The atlas identifies known fAD mutations and reveals that many variants beyond substitutions accelerate Aβ aggregation and are likely to be pathogenic. Truncations, substitutions, insertions, single- and internal multi-AA deletions differ in their propensity to enhance or impair aggregation, but likely pathogenic variants from all classes are highly enriched in the polar N-terminal region of Aβ. This comparative atlas highlights the importance of including diverse mutation types in MAVEs and provides important mechanistic insights into amyloid nucleation., M.S. was supported by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). Work in the lab of BB and BL is supported by the la Caixa Research Foundation project ‘DeepAmyloids’ (LCF/PR/HR21/52410004). Work in the lab of BB is also supported by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I, funded by MCIN/AEI/ 10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and the CERCA Program/Generalitat de Catalunya. Work in the lab of BL is also supported by a European Research Council (ERC) Advanced Grant (‘Mutanomics’ 883742), the Spanish Ministry of Science, Innovation and Universities (PID2020-118723GB-I00), the Bettencourt Schueller Foundation, the AXA Research Foundation, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership and the Centro de Excelencia Severo Ochoa. We thank the Chernoff lab for providing strains and plasmids and the CRG Genomics core technology for sequencing. We also thank Andre Faure and Marta Badia for advice on data analysis, Leire Moriones for assistance with validation experiments and Xavier Salvatella and Carla Garcia for discussing our data.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Massively parallel genetic perturbation suggests the energetic structure of an amyloid-β transition state

  • Arutyunyan, Anna
  • Seuma, Mireia
  • Faure, Andre J.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Amyloid aggregates are pathological hallmarks of many human diseases, but how soluble proteins nucleate to form amyloids is poorly understood. Here, we use combinatorial mutagenesis, a kinetic selection assay, and machine learning to massively perturb the energetics of the nucleation reaction of amyloid-β (Aβ42), the protein that aggregates in Alzheimer's disease. In total, we measure the nucleation rates of >140,000 variants of Aβ42 to accurately quantify the changes in free energy of activation of the reaction for all possible amino acid substitutions in a protein and, in addition, to quantify >600 energetic interactions between mutations. Strong energetic couplings suggest that the Aβ42 nucleation reaction transition state is structured in a short C-terminal region, providing a structural model for the reaction that may initiate Alzheimer's disease. Using this approach it should be possible to reveal the energetic structures of additional amyloid transition states and, in combination with additional selection assays, protein transition states more generally., This work was funded by the La Caixa Research Foundation project “DeepAmyloids” (LCF/PR/HR21/52410004). Work in the lab of B.B. was also funded by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I funded by MCIN/AEI/10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and by the European Union (ERC Consolidator, Glam-MAP, 101125484). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. Work in the lab of B.L. was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). M.S. was funded by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Massive experimental quantification allows interpretable deep learning of protein aggregation

  • Thompson, Mike
  • Martín, Mariano
  • Sanmartín Olmo, Trinidad
  • Rajesh, Chandana
  • Koo, Peter K.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Protein aggregation is a pathological hallmark of more than 50 human diseases and a major problem for biotechnology. Methods have been proposed to predict aggregation from sequence, but these have been trained and evaluated on small and biased experimental datasets. Here we directly address this data shortage by experimentally quantifying the aggregation of >100,000 protein sequences. This unprecedented dataset reveals the limited performance of existing computational methods and allows us to train CANYA, a convolution-attention hybrid neural network that accurately predicts aggregation from sequence. We adapt genomic neural network interpretability analyses to reveal CANYA's decision-making process and learned grammar. Our results illustrate the power of massive experimental analysis of random sequence-spaces and provide an interpretable and robust neural network model to predict aggregation., This work received support from the following: “La Caixa” Foundation (ID 100010434) under grant agreement LCF/PR/HR21/52410004 (B.L.); European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme grant agreement 883742 (B.L.); AXA Research Fund AXA Chair in Risk prediction in age-related diseases (B.L.); Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and the European Social Funds 2017 SGR 1322 (B.L.); Bettencourt Schueller Foundation (B.L.); PID2023-146685NB-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE; Wellcome 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026” (B.L.); Spanish Ministry of Science, Innovation and Universities PID2021-127761OB-I00 (B.B.) RYC2020-028861-I funded by MCIN/AEI/ 10.13039/501100011033 “ERDF A way of making Europe” and “ESF Investing in your future” (B.B.); European Union (ERC Consolidator, Glam-MAP, 101125484) (B.B.); EMBO Fellowship ALTF 266-2023 (M.T.); NIH grant R01HG012131 (P.K. and C.R.); and NIH grant R01GM149921 (P.K. and C.R.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation

  • Seuma, Mireia
  • Lehner, Ben, 1978-
  • Bolognesi, Benedetta
Multiplexed assays of variant effects (MAVEs) guide clinical variant interpretation and reveal disease mechanisms. To date, MAVEs have focussed on a single mutation type-amino acid (AA) substitutions-despite the diversity of coding variants that cause disease. Here we use Deep Indel Mutagenesis (DIM) to generate a comprehensive atlas of diverse variant effects for a disease protein, the amyloid beta (Aβ) peptide that aggregates in Alzheimer's disease (AD) and is mutated in familial AD (fAD). The atlas identifies known fAD mutations and reveals that many variants beyond substitutions accelerate Aβ aggregation and are likely to be pathogenic. Truncations, substitutions, insertions, single- and internal multi-AA deletions differ in their propensity to enhance or impair aggregation, but likely pathogenic variants from all classes are highly enriched in the polar N-terminal region of Aβ. This comparative atlas highlights the importance of including diverse mutation types in MAVEs and provides important mechanistic insights into amyloid nucleation., M.S. was supported by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). Work in the lab of BB and BL is supported by the la Caixa Research Foundation project ‘DeepAmyloids’ (LCF/PR/HR21/52410004). Work in the lab of BB is also supported by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I, funded by MCIN/AEI/ 10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and the CERCA Program/Generalitat de Catalunya. Work in the lab of BL is also supported by a European Research Council (ERC) Advanced Grant (‘Mutanomics’ 883742), the Spanish Ministry of Science, Innovation and Universities (PID2020-118723GB-I00), the Bettencourt Schueller Foundation, the AXA Research Foundation, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership and the Centro de Excelencia Severo Ochoa. We thank the Chernoff lab for providing strains and plasmids and the CRG Genomics core technology for sequencing. We also thank Andre Faure and Marta Badia for advice on data analysis, Leire Moriones for assistance with validation experiments and Xavier Salvatella and Carla Garcia for discussing our data.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Massive experimental quantification allows interpretable deep learning of protein aggregation

  • Thompson, Mike
  • Martín, Mariano
  • Sanmartín Olmo, Trinidad
  • Rajesh, Chandana
  • Koo, Peter K.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Protein aggregation is a pathological hallmark of more than 50 human diseases and a major problem for biotechnology. Methods have been proposed to predict aggregation from sequence, but these have been trained and evaluated on small and biased experimental datasets. Here we directly address this data shortage by experimentally quantifying the aggregation of >100,000 protein sequences. This unprecedented dataset reveals the limited performance of existing computational methods and allows us to train CANYA, a convolution-attention hybrid neural network that accurately predicts aggregation from sequence. We adapt genomic neural network interpretability analyses to reveal CANYA's decision-making process and learned grammar. Our results illustrate the power of massive experimental analysis of random sequence-spaces and provide an interpretable and robust neural network model to predict aggregation., This work received support from the following: “La Caixa” Foundation (ID 100010434) under grant agreement LCF/PR/HR21/52410004 (B.L.); European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme grant agreement 883742 (B.L.); AXA Research Fund AXA Chair in Risk prediction in age-related diseases (B.L.); Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and the European Social Funds 2017 SGR 1322 (B.L.); Bettencourt Schueller Foundation (B.L.); PID2023-146685NB-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE; Wellcome 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026” (B.L.); Spanish Ministry of Science, Innovation and Universities PID2021-127761OB-I00 (B.B.) RYC2020-028861-I funded by MCIN/AEI/ 10.13039/501100011033 “ERDF A way of making Europe” and “ESF Investing in your future” (B.B.); European Union (ERC Consolidator, Glam-MAP, 101125484) (B.B.); EMBO Fellowship ALTF 266-2023 (M.T.); NIH grant R01HG012131 (P.K. and C.R.); and NIH grant R01GM149921 (P.K. and C.R.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Massively parallel genetic perturbation suggests the energetic structure of an amyloid-β transition state

  • Arutyunyan, Anna
  • Seuma, Mireia
  • Faure, Andre J.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Amyloid aggregates are pathological hallmarks of many human diseases, but how soluble proteins nucleate to form amyloids is poorly understood. Here, we use combinatorial mutagenesis, a kinetic selection assay, and machine learning to massively perturb the energetics of the nucleation reaction of amyloid-β (Aβ42), the protein that aggregates in Alzheimer's disease. In total, we measure the nucleation rates of >140,000 variants of Aβ42 to accurately quantify the changes in free energy of activation of the reaction for all possible amino acid substitutions in a protein and, in addition, to quantify >600 energetic interactions between mutations. Strong energetic couplings suggest that the Aβ42 nucleation reaction transition state is structured in a short C-terminal region, providing a structural model for the reaction that may initiate Alzheimer's disease. Using this approach it should be possible to reveal the energetic structures of additional amyloid transition states and, in combination with additional selection assays, protein transition states more generally., This work was funded by the La Caixa Research Foundation project “DeepAmyloids” (LCF/PR/HR21/52410004). Work in the lab of B.B. was also funded by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I funded by MCIN/AEI/10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and by the European Union (ERC Consolidator, Glam-MAP, 101125484). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. Work in the lab of B.L. was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). M.S. was funded by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR).